Biotechnology VALUE FUND L P, 10% Owner at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 2,565,712 shares at $26.65 ($68.4M) on 2017-12-19, disclosed to the SEC on 2017-12-21.
Open-market sale of $68.4M CNCE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.65 | 169,292 | $4.5M | 6.6% |
| 2 | $26.65 | 169,292 | $4.5M | 6.6% |
| 3 | $26.65 | 445,615 | $11.9M | 17.4% |
| 4 | $26.65 | 445,615 | $11.9M | 17.4% |
| 5 | $26.65 | 667,949 | $17.8M | 26.0% |
| 6 | $26.65 | 667,949 |
| $17.8M |
| 26.0% |
| Total | $26.65 avg | 2,565,712 | $68.4M | 100% |
| Filing → |
| KYMR | BUY | 2022-05-24 | $141K | — | Filing → |
| OLMA | BUY | 2021-12-02 | $13.9M | — | Filing → |
| KYMR | BUY | 2021-07-06 | $25.6M | — | Filing → |